Table 2.
Groups | Portal inflammation | Lytic necrosis | Knodell scorea | Interpretation | |
---|---|---|---|---|---|
15 days | Control | 0 | 0 | 0 | No inflammation |
0.5 ppm | 0 | 0 | 0 | No inflammation | |
5 ppm | 1 | 1 | 2 | Minimal inflammation | |
20 ppm | 1 | 1 | 2 | Minimal inflammation | |
30 days | Control | 0 | 0 | 0 | No inflammation |
0.5 ppm | 0 | 1 | 1 | Minimal inflammation | |
5 ppm | 1 | 1 | 2 | Minimal inflammation | |
20 ppm | 1 | 3 | 4 | Minimal inflammation | |
60 days | Control | 0 | 0 | 0 | No inflammation |
0.5 ppm | 1 | 3 | 4 | Minimal inflammation | |
5 ppm | 3 | 3 | 6 | Mild inflammation | |
20 ppm | 3 | 3 | 6 | Mild inflammation | |
Portal inflammation: 0, no portal inflammation, 1, mild (sprinkling of inflammatory cells in < 1/3 of portal tracts), 3, moderate (increased inflammatory cells in 1/3–2/3 of portal tracts), 4, marked (dense packing of inflammatory cells in > 2/3 of portal tracts). |
Necrosis: 0, none, 1, mild (acidophilic bodies, ballooning degeneration, and/ or scattered foci of hepatocellular necrosis in < 1/3 of lobules or nodules) 3, moderate (involvement of 1/3–2/3 of lobules or nodules) 4, marked (involvement of > 2/3 of lobules or nodules) |
0 = no inflammation, 1–4 = minimal inflammation, 5–8 = mild inflammation, 9–12 = moderate inflammation and 13–18 = marked inflammation
aKnodell HAI score is the combined scores for periportal necrosis, intralobular necrosis, portal inflammation, and fibrosis to yield a possible range of 0–22. As used in clinical trials, the first three categories are often totaled to give a necroinflammatory score (0–18), while the fibrosis score (0–4) is reported separately